Bulletin
Investor Alert

Alpine Immune Sciences Inc.

NAS: ALPN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204491010/composite

$

9.00

Change

+0.33 +3.81%

Volume

Volume 74

Sep 18, 2020, 5:19 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204491010/composite

Previous close

$ 8.33

$ 8.67

Change

+0.34 +4.08%

Day low

Day high

$8.34

$9.32

Open
Open: 8.46

52 week low

52 week high

$2.05

$15.00

Open

Market cap

$206.21M

Average volume

86,760

P/E ratio

N/A

Rev. per Employee

$14,688

EPS

-1.78

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alpn

MarketWatch News on ALPN

  1. Elliott Associates Wants Bit Changes at eBay

    2:39 p.m. Feb. 27, 2019

    - Barron's Online

  2. Alpine Immune Sciences started at outperform with $13 stock price target at Raymond James

    8:28 a.m. Aug. 14, 2018

    - Tomi Kilgore

  3. Alpine Immune Sciences started at outperform with $13 stock price target at Oppenheimer

    8:51 a.m. June 29, 2018

    - Tomi Kilgore

  4. Alpine Immune Sciences initiated at outperform at Wedbush

    7:58 a.m. May 18, 2018

    - Ciara Linnane

  5. Alpine Immune Sciences upgraded to buy from hold at Stifel Nicolaus

    8:47 a.m. Sept. 22, 2017

    - Tomi Kilgore

  6. Alpine Immune Services started at buy with $17 stock price target at Ladenburg Thalmann

    8:57 a.m. July 27, 2017

    - Tomi Kilgore

  7. Nivalis Therapeutics downgraded to market perform from outperform at Raymond James

    9:18 a.m. Nov. 29, 2016

    - Tomi Kilgore

  8. Nivalis Therapeutics' stock plunges 54% premarket after disappointing trial results late Monday

    8:58 a.m. Nov. 29, 2016

    - Tomi Kilgore

  9. Nivalis Therapeutics downgraded to hold from buy at Stifel Nicolaus

    8:14 a.m. Nov. 29, 2016

    - Tomi Kilgore

  10. Nivalis Therapeutics downgraded to neutral from outperform at RW Baird

    8:12 a.m. Nov. 29, 2016

    - Tomi Kilgore

  11. Nivalis Therapeutics plummet as cystic fibrosis drug study fails

    5:40 p.m. Nov. 28, 2016

    - Wallace Witkowski

  12. Nivalis Therapeutics started at outperform with $20 stock price target at Raymond James

    8:53 a.m. Sept. 13, 2016

    - Tomi Kilgore

  13. Nivalis Therapeutics started at buy, $23 stock price target at Stifel Nicolaus

    7:29 a.m. July 13, 2015

    - Tomi Kilgore

  14. Novellus Raises Q4 Shipment, Bookings View

    8:46 p.m. May 5, 2017

    - Barrons Blogs

  15. Novellus: Stifel Says Hold On Valuation

    8:45 p.m. May 5, 2017

    - Barrons Blogs

  16. Buyout Time? Shopping For LBOs In Chip, Equipment Sectors

    8:43 p.m. May 5, 2017

    - Barrons Blogs

  17. Lam Research: Citi Sees Push Outs From Samsung, Shrs Slide

    8:42 p.m. May 5, 2017

    - Barrons Blogs

  18. Novellus Q3 Edges Street Ests

    8:39 p.m. May 5, 2017

    - Barrons Blogs

  19. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alpn

Other News on ALPN

  1. New Strong Sell Stocks for September 8th

    8:57 a.m. Sept. 8, 2020

    - Zacks.com

  2. Alpine Immune Sciences (ALPN) Investor Presentation - Slideshow

    6:03 p.m. Aug. 13, 2020

    - Seeking Alpha

  3. 10-Q: ALPINE IMMUNE SCIENCES, INC.

    4:54 p.m. Aug. 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. United Therapeutics (UTHR) Q2 Earnings In Line, Sales Beat

    11:41 a.m. July 30, 2020

    - Zacks.com

  5. Alpine Immune Sciences secures equity capital of $60M

    9:46 a.m. July 24, 2020

    - Seeking Alpha

  6. Alpine Immune Sciences reports NEON-1 Phase 1 trial of ALPN-202

    10:21 a.m. June 24, 2020

    - Seeking Alpha

  7. IBN, EDIT among premarket losers

    8:15 a.m. June 24, 2020

    - Seeking Alpha

  8. NIO, SPCE among premarket gainers

    8:21 a.m. June 22, 2020

    - Seeking Alpha

  9. Alpine Skyrockets on License Deal With AbbVie for ALPN-101

    11:27 a.m. June 19, 2020

    - Zacks.com

  10. Company News for Jun 19, 2020

    9:32 a.m. June 19, 2020

    - Zacks.com

  11. WKHS, CDEV among premarket gainers

    8:24 a.m. June 19, 2020

    - Seeking Alpha

  12. NES, ISEE, QUIK and BBI among midday movers

    12:44 p.m. June 18, 2020

    - Seeking Alpha

  13. Alpine Immune Sciences inks deal with AbbVie for lead drug

    8:25 a.m. June 18, 2020

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/alpn

Press Releases on ALPN

  1. Alpine Immune Sciences Announces $60 Million Private Placement

    9:15 a.m. July 24, 2020

    - BusinessWire - BZX

  2. AbbVie’s $60 Million Bet On Penny Stocks

    10:21 a.m. June 18, 2020

    - Penny Stocks

  3. Alpine Immune Sciences Announces Poster Presentations at EULAR 2020

    8:00 a.m. May 29, 2020

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.